RushPR News – Lifestyle
Author:
Disc Medicine Inc
Disc Medicine to Participate in Upcoming Investor Conferences
May 11, 2026
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026